Drug Pricing
Blog
When the Public Option Is the Only Option
Single-payer has failed abroad and at home. Yet the call for single-payer from progressives has never been louder. Vermont senator Bernie Sanders (I-VT) and his dedicated followers have been the loudest. In his campaign for the Democratic presidential nomination in 2016, he promised “Medicare for All.” In September 2017, he ...
Commentary
Trump’s Drug Pricing Speech Mostly Hit the Right Notes
Last Friday, President Trump delivered a major speech from the White House Rose Garden on prescription drug prices. He announced several policies aimed at reducing the overall cost of pharmaceuticals and limiting patients’ out-of-pocket expenses. His reform agenda, entitled “American Patients First,” is largely excellent. It mostly harnesses the power ...
Business & Economics
Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois
Due to its national implications, last week’s introduction of the Department of Health and Human Services’ (HHS) blueprint on drug prices is garnering all the attention. Despite its importance, HHS’ blueprint should not overshadow the many poor, and even unconstitutional, policy proposals that are occurring at the state level. For ...
Business & Economics
Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects
Health care is becoming less affordable every year. Over the past 10 years, national healthcare expenditures have grown 45 percent, but our economy has grown only 28 percent. This isn’t sustainable; and, solving this problem should be a top policy priority. However, “rounding up the usual suspects,” as Captain Renault ...
Commentary
Just Say No to Drug Imports
A U.S. district court in Montana just imposed a $34 million fine on Canada Drugs, an online pharmacy charged with selling counterfeit medications to unsuspecting Americans. Some of the drugs contained no active ingredients. Canada Drugs isn’t the only online pharmacy that puts patients’ lives in serious jeopardy. The National Association ...
Blog
Single-Payer in California: Slowly, Slowly, Catchy Monkey
For now, California’s progressive politicians have judged single-payer as a bridge too far. But that doesn’t mean they’ve given up trying to take over health care. As my Canadian mother used to say, “slowly, slowly, catchy monkey” – or be patient. On March 14, Assembly lawmakers released a report by ...
Business & Economics
Report Slams 340B Drug Discount Program
By Tracey Walker The 340B Drug Discount program, designed to give discounted prescription drugs to poor Americans, has not been effective in serving its targeted population, according to a new report. The report, “Addressing the Problems of Abuse in the 340B Drug Pricing Program,” by the Pacific Research Institute, found that the ...
Commentary
Trump Already Making Progress on Making Prescription Drugs Affordable
During Tuesday’s State of the Union address, President Trump pledged to drive down drug prices. That’s a worthy goal. And fortunately, the Trump administration is already pursuing it in a way that protects patients and encourages research and development. Many of the strategies that candidate Trump proposed on the campaign ...
Blog
The Importance of the Banal: The Case of the 340B Program
Most news coverage focuses on the grandiose – repeal of the Affordable Care Act (aka Obamacare), or whether the U.S. should implement a single payer health care system. These existential questions matter of course – a lot. Click on the image above to read Wayne Winegarden’s study, “Addressing the Problems ...
Drug Pricing
Report: 340B Drug Program Rife with Abuse, Profiteering
A program designed to help poor people afford prescription drugs is being used by hospitals to generate easy profits, according to a Pacific Research Institute report. A well-intended program designed to help poor people obtain prescription drugs is riddled with abuse and creates a perverse incentive for healthcare providers to ...
When the Public Option Is the Only Option
Single-payer has failed abroad and at home. Yet the call for single-payer from progressives has never been louder. Vermont senator Bernie Sanders (I-VT) and his dedicated followers have been the loudest. In his campaign for the Democratic presidential nomination in 2016, he promised “Medicare for All.” In September 2017, he ...
Trump’s Drug Pricing Speech Mostly Hit the Right Notes
Last Friday, President Trump delivered a major speech from the White House Rose Garden on prescription drug prices. He announced several policies aimed at reducing the overall cost of pharmaceuticals and limiting patients’ out-of-pocket expenses. His reform agenda, entitled “American Patients First,” is largely excellent. It mostly harnesses the power ...
Pharmaceutical Price Controls Will Not Improve Health Care Outcomes in Illinois
Due to its national implications, last week’s introduction of the Department of Health and Human Services’ (HHS) blueprint on drug prices is garnering all the attention. Despite its importance, HHS’ blueprint should not overshadow the many poor, and even unconstitutional, policy proposals that are occurring at the state level. For ...
Creating an Affordable Health Care System Requires More than Rounding Up the Usual Suspects
Health care is becoming less affordable every year. Over the past 10 years, national healthcare expenditures have grown 45 percent, but our economy has grown only 28 percent. This isn’t sustainable; and, solving this problem should be a top policy priority. However, “rounding up the usual suspects,” as Captain Renault ...
Just Say No to Drug Imports
A U.S. district court in Montana just imposed a $34 million fine on Canada Drugs, an online pharmacy charged with selling counterfeit medications to unsuspecting Americans. Some of the drugs contained no active ingredients. Canada Drugs isn’t the only online pharmacy that puts patients’ lives in serious jeopardy. The National Association ...
Single-Payer in California: Slowly, Slowly, Catchy Monkey
For now, California’s progressive politicians have judged single-payer as a bridge too far. But that doesn’t mean they’ve given up trying to take over health care. As my Canadian mother used to say, “slowly, slowly, catchy monkey” – or be patient. On March 14, Assembly lawmakers released a report by ...
Report Slams 340B Drug Discount Program
By Tracey Walker The 340B Drug Discount program, designed to give discounted prescription drugs to poor Americans, has not been effective in serving its targeted population, according to a new report. The report, “Addressing the Problems of Abuse in the 340B Drug Pricing Program,” by the Pacific Research Institute, found that the ...
Trump Already Making Progress on Making Prescription Drugs Affordable
During Tuesday’s State of the Union address, President Trump pledged to drive down drug prices. That’s a worthy goal. And fortunately, the Trump administration is already pursuing it in a way that protects patients and encourages research and development. Many of the strategies that candidate Trump proposed on the campaign ...
The Importance of the Banal: The Case of the 340B Program
Most news coverage focuses on the grandiose – repeal of the Affordable Care Act (aka Obamacare), or whether the U.S. should implement a single payer health care system. These existential questions matter of course – a lot. Click on the image above to read Wayne Winegarden’s study, “Addressing the Problems ...
Report: 340B Drug Program Rife with Abuse, Profiteering
A program designed to help poor people afford prescription drugs is being used by hospitals to generate easy profits, according to a Pacific Research Institute report. A well-intended program designed to help poor people obtain prescription drugs is riddled with abuse and creates a perverse incentive for healthcare providers to ...
